S&P assigns ‘BBB-‘ rating to Henry Mayo Newhall Hospital’s bonds

S&P Global Ratings assigned a “BBB-” rating to Valencia, Calif.-based Henry Mayo Newhall Hospital’s $110 million of series 2017 bonds.

Advertisement

The financial service provider also affirmed the “BBB-” underlying rating on the hospital’s $70 million of series 2014 revenue bonds.

“The ratings reflect our view of Henry Mayo’s strong cash flow despite industry challenges, because of its healthy payer mix and management’s attention to enhancing service lines and controlling costs,” said S&P analyst Allison Bretz.

The outlook is stable.

More articles on healthcare finance:
S&P lowers Richmond Hospital Authority’s rating to ‘A-‘
S&P revises Beaver Dam Community Hospital’s outlook to stable
Moody’s revises Lake Health’s outlook to negative

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.